, Tracking Stock Market Picks
Enter Symbol:
Keryx Biopharmaceuticals, Inc. (KERX) [hlAlert]

up 151.21 %

Keryx Biopharmaceuticals, Inc. (KERX) rated Underperform by FBR Capital

Posted on: Tuesday,  Dec 2, 2014  11:25 AM ET by FBR Capital

FBR Capital rated Underperform Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on 12/02/2014, when the stock price was $15.45. Since then, Keryx Biopharmaceuticals,
Inc. has lost 60.19% of its value until FBR Capital rated KERX Mkt Perform on 08/11/2015, when the price was $6.15.
If you would have followed this FBR Capital's recommendation on KERX, you would have gained 151.21% of your investment in 252 days.

Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.

FBR Capital uses a highly disciplined analysis focused on intrinsic value, which we developed to critically examine the capital structure of the companies we cover, as well as their competitive positions and the growth opportunities within their industries. We apply this discipline – which helps us assess how effectively a company’s managers deploy the capital entrusted to them – not only in our published research but also when making investing and underwriting judgments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/11/2015 8:25 AM Hold
6.15 10.00
as of 10/17/2014
1 Week down  -2.60 %
1 Month down  -12.27 %
3 Months up  4.23 %
1 YTD up  4.23 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/2/2014 11:25 AM Sell
9/8/2014 8:25 AM Sell

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy